Peritoneal Delivery of Sodium Pyrophosphate Blocks the Progression of Pre-existing Vascular Calcification in Uremic Apolipoprotein-E Knockout Mice

Effects of pyrophosphate delivery in a peritoneal dialysis solution on bone tissue of apolipoprotein-E knockout mice with chronic kidney disease

(2014) Fellype C. Barreto et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Vascular calcification is dependent on plasma levels of pyrophosphate

(2014) Koba A. Lomashvili et al.   KIDNEY INTERNATIONAL

Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

(2013) Julia J. Scialla et al.   KIDNEY INTERNATIONAL

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis

(2013) Sophie A Jamal et al.   LANCET

Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease

(2012) H. Vlassara et al.   Clinical Journal of the American Society of Nephrology

Phosphorus Is Associated with Coronary Artery Disease in Patients with Preserved Renal Function

(2012) Ana Ludimila Cancela et al.   PLoS One

Calcium Phosphate Deposition With Normal Phosphate Concentration

(2011) Ricardo Villa-Bellosta et al.   CIRCULATION JOURNAL

Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate

(2011) Catherine M. Shanahan et al.   CIRCULATION RESEARCH

Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia

(2011) B. L. Riser et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice

(2011) I. G. Nikolov et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages

(2011) L. Desjardins et al.   OSTEOPOROSIS INTERNATIONAL

Bisphosphonate Use in Chronic Kidney Disease: Association with Adynamic Bone Disease in a Bone Histology Series

(2010) Richard Amerling et al.   BLOOD PURIFICATION

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

(2010) A. Michael Parfitt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Treatment with pyrophosphate inhibits uremic vascular calcification

(2010) W Charles O'Neill et al.   KIDNEY INTERNATIONAL

Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?

(2009) R. B. Oliveira et al.   Clinical Journal of the American Society of Nephrology

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

(2009) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A 1-Year Randomized Trial of Calcium Acetate Versus Sevelamer on Progression of Coronary Artery Calcification in Hemodialysis Patients With Comparable Lipid Control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study

(2008) Wajeh Qunibi et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE−/−) mice

(2008) Ognen Ivanovski et al.   ATHEROSCLEROSIS

Phosphate Binder Impact on Bone Remodeling and Coronary Calcification – Results from the BRiC Study

(2008) Daniela Veit Barreto et al.   NEPHRON CLINICAL PRACTICE

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE